Mr Ulises Lopez
Bellvitge University Hospital, Hospitalet De Llobregat (Spain)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Differences in patients with early and late toxic cardiomyopathy post-chemotherapy: characteristics and prognosis
Event: Heart Failure 2019
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
ESC 365 is supported by
